previous
two
bcell
epitop
enteropathogen
transmiss
gastroenter
viru
tgev
name
c
epitop
tgevc
amino
acid
aa
epitop
tgeva
aa
spike
protein
tgev
separ
express
fibrilla
surfac
escherichia
coli
follow
insert
region
clpg
howev
result
chimera
induc
margin
tgevneutr
antibodi
ab
respons
mice
view
improv
respons
introduc
tgevc
alon
differ
tandem
associ
tgeva
c
c
twelv
put
expos
region
clpg
among
result
engin
protein
carri
extra
aa
essenti
disturb
correct
fibrilla
format
process
six
partial
permiss
site
accept
tgevc
three
highli
permiss
site
toler
c
c
tandem
peptid
identifi
throughout
clpg
intact
bacteria
extract
hybrid
fibrilla
express
tgev
epitop
permiss
site
recogn
ab
direct
foreign
parent
protein
provid
direct
argument
exposur
correspond
clpg
region
cell
surfac
antigen
epitop
polymer
fibrilla
context
potenti
fibrilla
carrier
tgev
peptid
indic
may
three
posit
n
terminu
aa
clpg
may
turn
import
fusion
site
therefor
relev
eventu
design
tgev
vaccin
unexpectedli
tgeva
whatev
posit
clpg
mediat
partial
proteolyt
degrad
hybrid
protein
suggest
function
substrat
cellular
proteas
therebi
suitabl
vaccin
antigen
candid
doubt
ab
page
polyacrylamidegel
electrophoresi
pb
phosphatebuff
salin
mm
ph
sd
sodium
dodecyl
sulfat
tb
trisbuff
salin
mm
ph
tgev
transmiss
gastroenter
viru
tgeva
peptidesiteepitop
tgev
tgevc
peptidesiteepitop
c
tgev
tgev
spike
glycoprotein
tgev
wt
wild
type
novel
junction
fusion
insert
denot
plasmidcarri
state
epitopebas
recombin
vaccin
technolog
offer
potenti
oral
mucos
deliveri
especi
relev
epitop
genet
fuse
carrier
protein
display
heterolog
peptid
surfac
bacteri
strain
rabinovich
et
al
howev
coupl
foreign
peptid
carrier
result
poor
immunogen
chimer
antigen
due
local
conform
restrict
impos
epitop
embed
structur
benito
et
al
therefor
approach
enhanc
immunogen
critic
sinc
conform
foreign
sequenc
within
carrier
vari
wide
depend
flank
sequenc
tishminetzki
et
al
insert
antigen
differ
expos
region
deliveri
protein
thu
chang
antigen
conform
could
permit
strategi
find
appropri
environ
peptid
present
among
complex
assort
molecular
context
offer
carrier
second
strategi
improv
immunogen
fusion
onelett
code
aa
design
use
number
vertic
arrow
nt
sequenc
indic
number
posit
twelv
select
insert
site
asterisk
denot
nt
modifi
sitedirect
mutagenesi
correspond
mutat
aa
residu
result
engin
restrict
site
spei
bglli
plasmid
bousquet
et
al
code
mutant
mention
ae
panel
c
repres
predict
secondari
structur
b
hydrophil
hatch
box
c
variabl
black
box
conserv
open
box
girardeau
et
al
mrchin
et
al
stanssen
et
al
perform
doublestrand
dna
use
adapt
protocol
method
jung
et
al
deng
nickoloff
mutat
verifi
dna
sequenc
sanger
et
al
oligo
use
studi
synthes
necessari
pagepurifi
eurogentec
belgium
oligo
shown
name
indic
number
parenthes
refer
nt
posit
code
strand
clpg
gene
see
c
bold
charact
repres
mutat
result
spei
site
introduct
cttcaagcagtaactagtaaccctaacgcg
caagcagtaaacactagtcctaacgcgggc
gcagtaaaccctactagtaacgcgggcaat
tandem
peptid
immunogen
carrier
protein
broekhuijsen
et
al
martineau
et
al
khan
et
al
third
strategi
might
insert
epitop
access
surfac
region
previous
observ
natur
immunodomin
site
nativ
carrier
molecul
develop
differ
approach
simultan
use
major
clpg
subunit
e
coli
fibrilla
carrier
protein
bousquet
et
al
der
vartanian
et
al
two
bcell
epitop
tgev
consist
site
c
aa
site
aa
tgev
foreign
antigen
determin
delma
et
al
gebauer
et
al
continu
site
c
elicit
neutral
ab
site
part
highli
immunogen
conform
antigen
region
delma
et
al
correa
et
al
tgeva
tgevc
insert
posit
aa
cipg
previous
shown
induc
low
neutral
ab
respons
mice
bousquet
et
al
aim
work
explor
recombin
clpg
tgev
protein
display
differ
combin
two
tgev
peptid
particular
context
could
result
improv
epitop
perform
thu
allow
design
vaccin
antigen
purpos
examin
permiss
charbit
et
al
fig
foreign
sequenc
use
studi
construct
chimer
clpg
gene
six
doublestrand
synthet
oligo
code
tgevc
oligo
l
tgeva
oligo
tgev
porcin
strain
tgev
shown
bold
aa
residu
correspond
residu
tgev
span
site
c
respect
restrict
site
underlin
introduc
tgevc
alon
tandem
tgeva
site
investig
influenc
result
modif
express
fibrilla
discuss
natur
permiss
site
posit
tandem
insert
effect
epitop
twelv
site
within
clpg
select
insert
tgev
peptid
fig
one
locat
n
terminfi
fig
other
distribut
along
aa
region
fig
region
contain
variabl
flexibl
loop
structur
aa
carri
hydrophil
domain
sever
access
continu
immunodomin
epitop
one
aa
expos
nativ
clpg
subunit
surfac
polymer
fibrilla
fig
reason
hypothes
region
aa
natur
favor
present
tgev
epitop
construct
insert
p
asmid
vector
preliminari
step
viral
epitop
insert
select
region
aa
clpg
fig
correspond
clpg
sequenc
submit
oligodeoxyribonucleotid
oligo
sitedirect
mutagenesi
creat
uniqu
restrict
site
differ
posit
within
sequenc
thu
spei
site
independ
engin
codon
express
everi
one
aa
compos
region
aa
fig
result
addit
dipeptid
threonineserin
ts
fig
aa
peptideencod
sequenc
yend
spei
site
yend
bglli
site
two
round
mutagenesi
induc
chang
clpg
fig
mutant
first
round
allow
insert
site
aa
second
replac
region
aa
strategi
clpg
tgev
hybrid
construct
use
engin
restrict
site
two
natur
occur
site
sphi
fig
muni
fig
uniqu
xhoi
site
speicompaf
end
spei
site
see
fig
legend
construct
insert
oligo
fig
xholcompat
end
xhoi
site
result
addit
oligo
correct
infram
revers
orient
respect
bousquet
et
al
made
replac
speibglii
fragment
see
fig
legend
oligo
fig
compat
end
construct
insert
oligo
contain
uniqu
xhoi
site
speicompat
end
spei
site
engin
clone
oligo
fig
compris
uniqu
xhoi
site
sphiflank
end
uniqu
sphi
site
obtain
insert
oligo
xhoicompat
end
xhoi
site
construct
two
step
first
step
oligo
includ
uniqu
nsii
site
sphiflank
end
clone
sphi
site
clpg
fig
second
step
nsii
site
oligo
allow
insert
oligo
fig
nsii
compat
end
downstream
oligo
made
insert
oligo
fig
municompat
end
muni
site
clpg
fig
construct
follow
spei
site
within
clpg
introduc
codon
express
everi
one
aa
residu
cover
region
cipg
fig
vitro
mutagenesi
use
oligo
fig
legend
obtain
insert
oligo
contain
xhoi
site
spei
compat
end
spei
site
respect
made
clone
oligo
xhoicompat
end
xhoi
site
respect
engin
respect
indic
except
oligo
insert
infram
revers
orient
design
letter
x
made
replac
munisaci
fragment
munisaci
fragment
c
presenc
oltgevc
specifi
letter
c
respect
ca
ac
fig
construct
summar
fig
describ
detail
fig
legend
total
mutant
obtain
twentyeight
contain
least
one
tgev
peptid
among
tgevc
c
c
fusion
final
modif
clpg
result
insert
aa
length
fig
mutant
plasmid
fig
transfer
e
coli
bear
transcompl
plasmid
cellsurfac
locat
correspond
hybrid
clpg
subunit
fig
fibrilla
determin
intact
cell
situ
coloni
immunoblot
isol
mutat
polym
immunodot
analysi
use
polyclon
ab
pab
tgevcspecif
mab
tgevaspecif
mab
shown
recombin
fibrilla
carri
least
one
tgev
peptid
fail
react
whatev
ab
contrast
remain
hybrid
capabl
expos
tgev
peptid
cell
surfac
correctli
assembl
fibrilla
nine
permiss
identifi
throughout
clpg
posit
aa
appear
permiss
target
sinc
largest
insert
aa
interfer
fibrilla
format
even
hybrid
protein
insert
aa
long
result
simultan
tandem
addit
two
tgev
peptid
posit
aa
incorpor
polym
posit
aa
less
residu
aa
toler
posit
aa
nonpermiss
sinc
except
two
extra
aa
hybrid
detect
nonpermiss
insert
locat
near
predict
ahelix
structur
target
conserv
aa
residu
fig
aa
contrast
permiss
site
exclud
clpgn
terminu
includ
predict
loop
fig
aa
like
flexibl
enough
accommod
larg
insert
indic
propos
cipg
topolog
mrchin
et
al
two
fulli
permiss
site
aa
locat
top
end
loop
six
partial
permiss
site
aa
target
region
immedi
begin
loop
data
suggest
relationship
permiss
clpg
local
cipg
structur
epitop
insert
basi
result
conclud
clpg
carrier
flexibl
sinc
insert
vari
length
natur
made
differ
site
without
affect
format
hybrid
clpg
subunit
display
least
one
tgev
peptid
character
western
immunoblot
analysi
fig
protein
clp
migrat
singl
band
correspond
expect
fulllength
hybrid
sinc
reveal
anticlpg
pab
fig
b
c
mutant
show
two
protein
product
react
anticlpg
fig
upper
band
detect
three
ab
repres
whole
fusion
molecul
abund
major
lower
band
recogn
anticlpg
minor
lower
band
addit
mab
fig
two
uppermost
band
light
whatev
ab
fig
b
c
two
lowermost
band
anticlpg
ab
fig
b
observ
indic
hybrid
carri
tgeva
subject
incomplet
proteolysi
howev
prevent
format
fig
gener
way
clpg
hybrid
contain
tgeva
react
faintli
mab
fig
peptid
c
tandem
x
cryptic
peptid
encod
oligo
fig
insert
inphas
revers
orient
aa
chang
result
engin
tgev
epitopesencod
oligo
fig
cipg
number
refer
indic
first
last
aa
residu
wildtyp
wt
cipg
sequenc
residu
origin
clpg
protein
small
charact
addit
residu
larg
bold
type
hatch
box
tgevc
black
box
tgeva
open
box
cryptic
peptid
x
tqqadhsqiss
e
total
number
ad
aa
respect
wt
cipg
f
fibrilla
biogenesi
synthesi
synthesi
respect
method
product
hybrid
polym
detect
situ
coloni
immunoblot
immunodot
analysi
coloni
blot
analysi
singl
coloni
streak
solid
agar
lb
plate
contain
appropri
antibiot
overnight
incub
nitrocellulos
filter
pore
diamet
tm
schleicher
schuell
care
appli
agar
surfac
blot
block
wash
tween
pb
bulk
bacteria
remov
filter
incub
appropri
primari
ab
bsa
pb
bound
primari
ab
detect
incub
filter
either
horseradish
peroxidaseconjug
antirabbit
antimous
secondari
ab
develop
immunodot
analysi
extract
mutat
fibrilla
bacteria
grow
overnight
lb
agar
medium
appropri
antibiot
care
scrape
suspend
pb
suspens
vigor
agit
min
top
mix
shaker
place
min
thermoelut
polym
centrifug
x
g
min
result
supernat
use
experi
fibrillaespecif
rabbit
antiserum
obtain
describ
girardeau
et
al
mab
delma
et
al
mab
gebauer
et
al
rais
respect
c
site
tgev
nativ
coronaviru
use
fig
legend
mix
equal
volum
x
laemmli
buffer
boil
min
separ
sdspage
semidri
electrotransf
onto
nitrocellulos
sheet
towbin
et
al
control
wt
fibrilla
produc
e
coil
western
blot
treat
describ
fig
legend
use
primari
ab
either
anticlpg
pab
b
mab
c
mab
pab
e
pab
clpg
subunitspecif
rabbit
antiserum
anticlpg
pab
obtain
describ
girardeau
et
al
peptid
gqlqavnpnagnrgq
peptid
tftnpvvsttqwsap
correspond
aa
residu
cipg
respect
synthet
peptid
obtain
neosystem
strasbourg
franc
puriti
determin
highperform
liquid
chromatographi
prepar
antisera
peptid
coupl
bsa
use
glutaraldehyd
sigma
rabbit
prime
intraderm
inject
gg
peptid
emulsifi
incomplet
freund
adjuv
boost
day
later
final
bled
day
last
immun
although
sequenc
nand
ctermin
part
cleav
product
cipg
tgev
hybrid
sever
line
evid
suggest
proteolyt
event
occur
within
tgeva
oligopeptid
truncat
product
hybrid
contain
one
copi
tgeva
detect
mab
proteolysi
happen
clpg
alon
associ
tgevc
chimera
differ
tgeva
sequenc
revers
orient
cleav
immunoblot
pattern
carri
two
copi
tgeva
consist
presenc
cleavag
site
within
copi
sinc
four
fragment
visual
impli
tgeva
fuse
n
terminu
clpg
cleav
fashion
similar
tgeva
ctermin
part
clpg
case
proteolyt
cleavag
would
result
ntermin
fragment
small
aa
detect
explain
truncat
product
visual
fig
probe
precis
nand
ctermin
part
truncat
protein
gener
use
two
addit
specif
pab
recogn
peptid
aa
aa
clpg
respect
insert
sequenc
abolish
bind
fig
mutant
construct
place
aa
upstream
clpg
tgev
epitop
fusion
junction
aa
downstream
western
immunoblot
indic
intact
molecul
react
intact
molecul
undetect
low
amount
fig
e
contrast
degrad
form
probe
fig
togeth
fact
cleav
form
detect
fig
fig
truncat
product
react
two
mab
fig
c
data
suggest
proteas
cleavag
occur
within
tgeva
furthermor
uncleav
form
substanti
abund
truncat
form
fig
contrast
show
promin
amount
cleav
product
indic
c
fusion
rather
c
fusion
significantli
reduc
cleavag
process
probabl
due
protect
placement
hydrophob
tgevc
motif
ntermin
end
tgeva
therefor
specul
site
cleavag
must
ntermin
locat
respect
tgeva
sequenc
support
hypothesi
two
first
aa
residu
tgeva
consist
lysin
k
arginin
r
often
involv
proteolyt
matur
viral
envelop
glycoprotein
moulard
et
al
assist
dutilloy
secretari
assist
dr
l
enjuan
dr
h
laud
provid
mab
mab
respect
work
support
grant
european
econom
commun
eclair
program
three
nonpermiss
site
aa
six
partial
permiss
site
aa
three
fulli
permiss
site
aa
identifi
throughout
cipg
latter
site
appear
versatil
target
sinc
largest
insert
consist
ta
residu
interfer
biogenesi
even
insert
aa
long
result
addit
tgevc
tgeva
tandem
peptid
posit
aa
normal
incorpor
polym
bind
tgevspecif
mab
hybrid
fibrilla
indic
tgev
antigen
determin
express
permiss
site
expos
clpg
protein
e
coli
cellsurfac
show
potenti
clpg
carrier
foreign
peptid
may
influenc
gener
predict
properti
local
sequenc
unlik
tgevc
tgeva
express
permiss
site
clpg
render
hybrid
protein
partial
suscept
proteolyt
degrad
indic
influenti
critic
fibrilla
integr
presum
provid
proteas
cleavag
site
fibrillum
appear
potent
cellsurfac
present
vector
tgev
epitop
hybrid
fibrilla
might
valuabl
tool
develop
compon
subunit
vaccin
whether
hybrid
fibrilla
induc
specif
ab
current
investig
clpg
exposur
vector
system
describ
provid
number
insert
site
therefor
varieti
flank
aa
sequenc
express
tgev
epitop
consequ
studi
immunogen
tgev
epitop
differ
context
clpg
improv
understand
relationship
flank
sequenc
immunogen
epitop
